New Delhi, Jul 29: The Delhi High Court has sought the stand of the Centre and the Food Safety and Standards Authority of India (FSSAI) on a petition that raises concerns about the long‑term health implications of non‑sugar sweeteners (NSS) and artificial sweeteners.
Justice Swarana Kanta Sharma on July 23 issued notice to the central government and FSSAI and directed them to file their replies within two weeks, according to a PTI report.
Petition claims and legal representation
The petition was filed by the Indian Sugar & Bio‑energy Manufacturers Association (ISMA). ISMA said its challenge is founded on scientific evaluations and risk assessments published by internationally recognised public‑health and food‑safety bodies, which it said point to potential long‑term harms from certain artificial sweeteners.
ISMA listed possible health concerns cited in those evaluations, including carcinogenicity, metabolic disorders, neurological effects, cardiovascular disease and alterations to the gut microbiome. The association argues these findings warrant a comprehensive, independent and India‑specific scientific assessment of NSS and artificial sweeteners.
The petitioner was represented before the court by senior advocates Rajshekhar Rao and Ankur Chhibber, instructed by law firm AKS Partners, the report said.
Reliefs sought from FSSAI and authorities
ISMA has sought multiple directions from the court aimed at strengthening regulatory oversight and public information. The principal prayers in the petition, as set out in the report, include requests that authorities:
- Direct the FSSAI to undertake a comprehensive, independent and India‑specific scientific evaluation into long‑term health implications of NSS and artificial sweeteners, including their impact on metabolic health, cardiovascular disease, carcinogenicity and neurological health.
- Issue public advisories, awareness measures and consumer guidance concerning potential health implications of prolonged consumption, with particular focus on children, adolescents, pregnant women, people with diabetes and other vulnerable groups.
- Ensure that packaging, labelling and marketing of products containing NSS and artificial sweeteners are not false, misleading or deceptive, including preventing portrayal as inherently “healthy”, “safe” or as unqualified substitutes for sugar without adequate and equally prominent disclosure.
Regulatory and public‑health context
The petition places the matter at the intersection of food safety regulation, consumer protection and public health. FSSAI—tasked with setting standards for food safety and labelling in India—will be required to respond to the court notice. Any order directing an India‑specific review could lead to updated guidance on permissible uses, labelling requirements or targeted advisories for at‑risk populations.
The association’s reference to assessments by international public‑health and food‑safety bodies mirrors global debate on certain artificial sweeteners, where some studies and risk reviews have prompted regulatory reassessments or stricter labelling in varied jurisdictions. The petition argues those signals justify an Indian evaluation tailored to national consumption patterns and vulnerable groups.
Next steps and potential consequences
The court has given the Centre and FSSAI two weeks to file their replies. Depending on the responses and subsequent court directions, possible outcomes include:
- An order directing FSSAI to commission or conduct an India‑specific risk assessment.
- Instructions to issue consumer advisories targeted at children, pregnant women, diabetics and other vulnerable groups.
- Regulatory action on labelling and marketing norms for products containing NSS and artificial sweeteners.
| Who | Role in petition |
|---|---|
| ISMA | Petitioner; cites international evaluations and seeks India‑specific review |
| FSSAI | Regulator; directed by court to respond to petition |
| Centre | Respondent along with FSSAI; to file reply in two weeks |
The case highlights increasing scrutiny of food additives and the balance regulators must strike between technological food innovations, industry interests and precautionary public‑health measures. The court’s proceedings will be watched by industry, consumer groups and public‑health stakeholders for any signals on future regulation and consumer guidance relating to artificial sweeteners.
Replies from the Centre and FSSAI, and any subsequent hearings, are expected to clarify whether the authorities will order fresh risk assessments or adopt other measures in response to the petition.